Cite

HARVARD Citation

    Mirouse, A. et al. (2019). Long‐Term Outcome of Ustekinumab Therapy for Behçet's Disease. Arthritis & rheumatology. 71 (10), pp. 1727-1732. [Online]. 
  
Back to record